HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy
ACS Applied Materials & Interfaces · 16.11.2026
DOI: 10.1021/acsami.6c18357 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 16.11.2026. Verfasst von Tae Eon Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, College of Engineering Pusan National University, Busan46241, Republic of Korea. Die Arbeit nennt 70 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Cutaneous melanoma is an aggressive skin cancer for which localized treatment remains difficult because of limited drug penetration through the stratum corneum and the systemic toxicity of conventional chemotherapy. Here, we developed a noninvasive physicochemical platform combining hyaluronic acid (HA)-functionalized paclitaxel-loaded solid lipid nanoparticles (SLNs) with high-intensity focused ultrasound (HIFU) for localized melanoma therapy. The optimized SLNs exhibited a hydrodynamic diameter of 134.6 ± 4.2 nm and a zeta potential of –22.3 ± 1.5 mV. HIFU induced changes in the structural organization of the lipid matrix, accelerating paclitaxel release and enhancing skin penetration. In vitro, SLNs with HIFU reduced B16F10 melanoma cell viability to below 20% while maintaining approximately 65% viability of HaCaT keratinocytes. The combined treatment increased intracellular ROS generation by 6.2-fold and enhanced apoptotic signaling. In ex vivo porcine skin, HIFU-assisted delivery of coumarin-6-loaded SLNs increased fluorescence penetration to approximately 1500 μm, compared with 750 μm without HIFU. In B16F10 tumor-bearing mice, topical SLNs combined with HIFU under mild hyperthermia (41–43 °C) achieved 90.1% tumor growth inhibition at Day 8, 81.5% tumor necrosis, and 86.5% TUNEL-positive cells without significant body-weight loss or treatment-related toxicity. These findings support HIFU-enhanced SLNs as a potential strategy for improving cutaneous paclitaxel delivery and suppressing localized melanoma growth.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical Engineering, College of Engineering Pusan National University, Busan46241, Republic of Korea.
- Department of Cogno-Mechatronics Engineering, School of Transdisciplinary Engineering, Pusan National University, Busan46241, Republic of Korea.
- Department of Bioengineering, College of Engineering, Hanyang University, Seoul04763, Republic of Korea.
ORCID-Profile: Tae Eon Park, Ki Su Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, T. E., Song, Y., Kim, J., & Kim, K. S. (2026). HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c18357
Vancouver
Park TE, Song Y, Kim J, Kim KS. HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c18357
BibTeX
@article{Park2026,
author = {Park, Tae Eon and Song, Yuon and Kim, Jeesu and Kim, Ki Su},
title = {HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c18357}
}
EUVIMED